Building the Future of AI-Driven Nanobody and Antibody Design
This image was generated by AI and may not depict real events.
A webinar hosted by Twist Bioscience will discuss the application of artificial intelligence to antibody and nanobody design, highlighting the Therapeutic Nanobody Profiler tool. The event will cover the role of AI in therapeutic design, computational strategies, and challenges in nanobody development.
A webinar on AI-driven nanobody and antibody design will be held on May 26, 2026. The event will discuss the application of artificial intelligence in therapeutic discovery. Charlotte Deane will introduce the Therapeutic Nanobody Profiler, an open-source tool for evaluating nanobody developability. The webinar will cover topics such as computational strategies for antibody development and the use of datasets in biologics discovery. It will also examine the opportunities and limitations of AI in drug development pipelines. The event aims to shape the future of biologic discovery by accelerating critical stages of antibody and nanobody design.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.